NEW YORK, April 8, 2025 /PRNewswire/ -- Baseball fans can now enjoy Colony Grill's famous thin-crust pizza on game days in The Bronx through a new partnership with the New York Yankees.

The stock market was having a strong day on Tuesday, with the Dow Jones Industrial Average ( DJINDICES: ^DJI ) , S&P 500 ( SNPINDEX: ^GSPC ) , and Nasdaq Composite ( NASDAQINDEX: ^IXIC ) all higher by about 2% as of 12:15 p.m. ET.However, the financial sector was one of the best-performing areas ...

Las Vegas, NV, April 08, 2025 ( GLOBE NEWSWIRE ) -- The Global Gaming League ( GGL ) , a global gaming entertainment and media company, announced today the raise of $10 million for its SAFE round led by Solyco Capital.

LAS VEGAS, April 8, 2025 /PRNewswire/ -- Resorts World Las Vegas announced the appointment of casino industry veteran Greg Shulman as Executive Vice President of International Marketing, effective March 17. With over 30 years of experience in the gaming industry, Shulman brings extensive player ...

Finn Wittrock and Alexandra Daddario as Milton and Catherine Hershey Principal Photography Begins May 2025 Across Pennsylvania HERSHEY, Pa., April 8, 2025 /PRNewswire/ -- HERSHEY, a major motion picture of chocolate pioneer Milton Hershey and his beloved wife Catherine, 'Kitty', is officially ...

In the current session, the stock is trading at $497.27, after a 3.26% increase. Over the past month, Northrop Grumman Inc. NOC stock increased by 0.64%, and in the past year, by 8.60%.

Newmont's NEM short percent of float has risen 13.12% since its last report. The company recently reported that it has 21.65 million shares sold short, which is 2.5% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.14 days to cover their ...

Expedia Group's EXPE short percent of float has risen 17.76% since its last report. The company recently reported that it has 7.07 million shares sold short, which is 6.63% of all regular shares that are available for trading.

Rallybio ended the RLYB212 FNAIT program after Phase 2 data showed drug levels failed to reach target concentration for efficacy. Dosing of RLYB116, Rallybio's C5 inhibitor, starts in Q2 2025 with PK/PD data from Cohorts 1 and 2 expected in Q3 and Q4 2025. With stocks plunging, steady income is ...

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Results from the HERCULES phase 3 study showed delay in disability progression in people living with non-relapsing secondary progressive multiple sclerosis